Literature DB >> 18657534

Effects of chronic citalopram treatment on 5-HT1A and 5-HT2A receptors in group- and isolation-housed mice.

Lydia Günther1, Sabine Liebscher, Monika Jähkel, Jochen Oehler.   

Abstract

Selective serotonin reuptake inhibitors (SSRI) are characterized by high clinical effectiveness and good tolerability. A 2-3 week delay in the onset of effects is caused by adaptive mechanisms, probably at the serotonergic (5-HT) receptor level. To analyze this in detail, we measured 5-HT(1A) and 5-HT(2A) receptor bindings in vitro after 3 weeks of citalopram treatment (20 mg/kg i.p. daily) in group-housed as well as isolation-housed mice, reflecting neurobiological aspects seen in psychiatric patients. Isolation housing increased somatodendritic (+52%) and postsynaptic (+30-95%) 5-HT(1A) as well as postsynaptic 5-HT(2A) receptor binding (+25-34%), which confirms previous findings. Chronic citalopram treatment did not induce alterations in raphe 5-HT(1A) autoreceptor binding, independent of housing conditions. Housing-dependent citalopram effects on postsynaptic 5-HT(1A) receptor binding were found with increases in group- (+11-42%) but decreases in isolation-housed (-11 to 35%) mice. Forebrain 5-HT(2A) receptor binding decreased between 11 and 38% after chronic citalopram administration, independent of housing conditions. Citalopram's long-term action comprises alterations at the postsynaptic 5-HT(1A) and 5-HT(2A) receptor binding levels. Housing conditions interact with citalopram effects, especially on 5-HT(1A) receptor binding, and should be more strongly considered in pharmacological studies. In general, SSRI-induced alterations were more pronounced and affected more brain regions in isolates, supporting the concept of a higher responsiveness in "stressed" animals. Isolation-induced receptor binding changes were partly normalized by chronic citalopram treatment, suggesting the isolation housing model for further analyses of SSRI effects, especially at the behavioral level.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18657534     DOI: 10.1016/j.ejphar.2008.07.011

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

1.  GPR30 is necessary for estradiol-induced desensitization of 5-HT1A receptor signaling in the paraventricular nucleus of the rat hypothalamus.

Authors:  C E McAllister; R D Creech; P A Kimball; N A Muma; Q Li
Journal:  Psychoneuroendocrinology       Date:  2012-01-20       Impact factor: 4.905

2.  Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients.

Authors:  Daniel R Rosell; Judy L Thompson; Mark Slifstein; Xiaoyan Xu; W Gordon Frankle; Antonia S New; Marianne Goodman; Shauna R Weinstein; Marc Laruelle; Anissa Abi-Dargham; Larry J Siever
Journal:  Biol Psychiatry       Date:  2010-06-15       Impact factor: 13.382

3.  Cerebral 5-HT2A receptor binding, but not mGluR2, is increased in tryptophan hydroxylase 2 decrease-of-function mice.

Authors:  Christinna V Jørgensen; Jacob P Jacobsen; Marc G Caron; Anders B Klein; Gitte M Knudsen; Jens D Mikkelsen
Journal:  Neurosci Lett       Date:  2013-09-17       Impact factor: 3.046

Review 4.  Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation?

Authors:  Montserrat Serra-Millàs
Journal:  World J Psychiatry       Date:  2016-03-22

5.  Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations.

Authors:  Ramin V Parsey; R Todd Ogden; Jeffrey M Miller; Adrienne Tin; Natalie Hesselgrave; Ellen Goldstein; Arthur Mikhno; Matthew Milak; Francesca Zanderigo; Gregory M Sullivan; Maria A Oquendo; J John Mann
Journal:  Biol Psychiatry       Date:  2010-05-23       Impact factor: 13.382

6.  Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder.

Authors:  Neil A Gray; Matthew S Milak; Christine DeLorenzo; R Todd Ogden; Yung-Yu Huang; J John Mann; Ramin V Parsey
Journal:  Biol Psychiatry       Date:  2013-01-29       Impact factor: 13.382

7.  Familial risk for mood disorder and the personality risk factor, neuroticism, interact in their association with frontolimbic serotonin 2A receptor binding.

Authors:  Vibe G Frokjaer; Maj Vinberg; David Erritzoe; William Baaré; Klaus Kähler Holst; Erik Lykke Mortensen; Haroon Arfan; Jacob Madsen; Terry L Jernigan; Lars Vedel Kessing; Gitte Moos Knudsen
Journal:  Neuropsychopharmacology       Date:  2009-12-30       Impact factor: 7.853

8.  Cerebral markers of the serotonergic system in rat models of obesity and after Roux-en-Y gastric bypass.

Authors:  Cecilia Ratner; Anders Ettrup; Marco Bueter; Mette E Haahr; Valérie Compan; Carel W le Roux; Barry Levin; Henrik H Hansen; Gitte M Knudsen
Journal:  Obesity (Silver Spring)       Date:  2012-03-26       Impact factor: 5.002

9.  Consequences of post-weaning social isolation on anxiety behavior and related neural circuits in rodents.

Authors:  Jodi L Lukkes; Michael J Watt; Christopher A Lowry; Gina L Forster
Journal:  Front Behav Neurosci       Date:  2009-08-20       Impact factor: 3.558

10.  Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality.

Authors:  Jeffrey M Miller; Kathleen G Brennan; Todd R Ogden; Maria A Oquendo; Gregory M Sullivan; J John Mann; Ramin V Parsey
Journal:  Neuropsychopharmacology       Date:  2009-05-20       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.